TScan Therapeutics announces reorganization to focus on solid-tumor cell therapy
TScan Therapeutics says it will reorganize to focus on in vivo cell therapy for solid tumors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.